Home > Personal Investment Vitae
Location: United States
Gender: Female
Asset investment style: Quantitative fundamental analysis
Market capitalization:
$8,678,274talentsVirtual portfolio value:
$5,521,217talentsNet overall return per annum:
19.26%AYA current rank order:
#7Asset investment philosophy:
Daisy Harvey trades U.S. stocks with the top #76 to #500 positive alpha signals.
Top 10 profitable stock transactions since January 2020Strategy
| Symbol | Company | Buy | Sell | Share Volume | Return (%) | Profit ($) |
|---|---|---|---|---|---|---|
| VATE | INNOVATE Corp. Common Stock | $0.53 | $4.14 | 56,283 | +681.13% | $203,182 |
| RMBL | RumbleOn Inc. Class B Common Stock | $0.36 | $7.95 | 24,133 | +2,108.33% | $183,169 |
| TOP | TOP Financial Group Limited Class A Ordinary Shares | $2.06 | $16.73 | 11,508 | +712.14% | $168,822 |
| LGVN | Longeveron Inc. Class A Common Stock | $3.45 | $26.25 | 2,347 | +660.87% | $53,512 |
| AXSM | Axsome Therapeutics Inc. Common Stock | $4.60 | $31.75 | 1,335 | +590.22% | $36,245 |
| LSCC | Lattice Semiconductor Corporation Common Stock | $6.97 | $48.04 | 881 | +589.24% | $36,183 |
| SQ | Block Inc. Class A Common Stock | $14.50 | $99.54 | 423 | +586.48% | $35,972 |
| FIVN | Five9 Inc. Common Stock | $16.31 | $110.10 | 376 | +575.05% | $35,265 |
| TRNS | Transcat Inc. Common Stock | $11.35 | $73.00 | 541 | +543.17% | $33,353 |
| GLOB | Globant S.A. Common Shares | $34.57 | $215.99 | 177 | +524.79% | $32,111 |
| Sum | $817,814 |
Top 10 current stock portfolio positions as of September 2026Strategy
| Symbol | Company | Price | Position | Capitalization |
|---|---|---|---|---|
| PXS | Pyxis Tankers Inc. Common Stock | $7.01 | 8,213 | $57,573 |
| SEI | Solaris Energy Infrastructure Inc. Class A Common Stock | $64.15 | 867 | $55,618 |
| BE | Bloom Energy Corporation Class A Common Stock | $258.49 | 213 | $55,058 |
| EPRX | Eupraxia Pharmaceuticals Inc. Common Stock | $8.02 | 6,814 | $54,648 |
| ROIV | Roivant Sciences Ltd. Common Shares | $40.94 | 1,270 | $51,993 |
| HUT | Hut 8 Corp. Common Stock | $90.60 | 559 | $50,645 |
| CMDB | Costamare Bulkers Holdings Limited Common Stock | $23.35 | 2,150 | $50,202 |
| SBS | Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) | $5.32 | 9,058 | $48,188 |
| ECO | Okeanis Eco Tankers Corp. Common Stock | $72.92 | 659 | $48,054 |
| TARS | Tarsus Pharmaceuticals Inc. Common Stock | $81.12 | 592 | $48,023 |
| Sum | $520,002 |
Top 20 investors
Top 20 influencers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Chanel Holden | |||
| @Andy Yeh Alpha | |||
Top 20 followers
| #1 - #5 | #6 - #10 | #11 - #15 | #15 - #20 |
|---|---|---|---|
| @Cloud Play | @TechBull22 | @Ru-Ting Yeh | @Syl_will |
| @Bob Hessonwitz | @Vincent Bonsai | @Jack hsu | @Apple |
| @Will | @Darren | @AJ Yeh | @ZimboDave |
| @Luminoalgo | @Sandra Martinazzison | @MRCASH1991 | @Bloom789 |
| @Duke | @Mo | @Amy | @Andy Cheung |
2019-07-31 11:34:00 Wednesday ET

AYA Analytica finbuzz podcast channel on YouTube July 2019 In this podcast, we discuss several topical issues as of July 2019: (1) All 18 systemical
2017-12-23 10:40:00 Saturday ET

Despite having way more responsibility than anyone else, top business titans such as Warren Buffett, Charlie Munger, and Oprah Winfrey often step away from
2019-03-31 11:40:00 Sunday ET

AYA Analytica free finbuzz podcast channel on YouTube March 2019 In this podcast, we discuss several topical issues as of March 2019: (1) Sargent-Wallac
2018-03-23 08:26:00 Friday ET

Personal finance and investment author Thomas Corley studies and shares the rich habits of self-made millionaires. Corley has spent 5 years studying the dai
2019-06-05 10:34:00 Wednesday ET

Fed Chair Jay Powell suggests that the recent surge in U.S. business debt poses moderate risks to the economy. Many corporate treasuries now carry about 40%
2025-06-13 08:23:00 Friday ET

What are the mainstream legal origins of President Trump’s new tariff policies? We delve into the mainstream legal origins of President Trump&rsquo